DrugPatentWatch Database Preview
BINOSTO Drug Profile
Which patents cover Binosto, and when can generic versions of Binosto launch?
Binosto is a drug marketed by Mission Pharma and is included in one NDA. There are two patents protecting this drug.
This drug has eleven patent family members in seven countries.
The generic ingredient in BINOSTO is alendronate sodium. There are twenty-five drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the alendronate sodium profile page.
Summary for BINOSTO
| International Patents: | 11 |
| US Patents: | 2 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 29 |
| Clinical Trials: | 1 |
| Patent Applications: | 22 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for BINOSTO |
| DailyMed Link: | BINOSTO at DailyMed |
Pharmacology for BINOSTO
| Drug Class | Bisphosphonate |
Medical Subject Heading (MeSH) Categories for BINOSTO
Synonyms for BINOSTO
| (4-Amino-1-hydroxy-1-phosphonobutyl)phosphonic Acid Monosodium Salt |
| (4-Amino-1-hydroxybutylidene)bisphosphonic acid monosodium salt |
| 129318-43-0 |
| 4-AMINO-1-HYDROXY-1-PHOSPHONOBUTYL PHOSPHONIC ACID,MONOSODIUM |
| 4-AMINO-1-HYDROXYBUTYLIDENE-1,1-BISPHOSPHONIC ACID MONOSODIUM SALT |
| 4-Amino-1-hydroxybutylidine-1,1-bisphosphonate |
| 4988K7X26P |
| A805927 |
| AB10152 |
| AC1Q1W16 |
| AHBuBP |
| AHButBP |
| AKOS015895071 |
| Alend |
| ALENDRONATE SODIUM |
| Alendronate sodium anhydrous |
| Alendronate, Sodium Salt |
| Alendronate, Sodium, Trihydrate |
| Alendronic Acid Monosodium Salt |
| Alendronic acid sodium salt |
| ALENDRONIC ACID, SODIUM |
| Alendronic acid, Sodium aldendronate |
| Almerol |
| AN-32438 |
| API0001401 |
| Avalent |
| BB_SC-02791 |
| BB_SC-2791 |
| BG0020 |
| Bonalon |
| C4H12NNaO7P2 |
| CAKRAHQRJGUPIG-UHFFFAOYSA-M |
| CCG-220631 |
| CHEMBL675 |
| EX-101 |
| Fosamac |
| Fosamax |
| G-704650 |
| GTH-42 |
| GTH-42J |
| GTH-42V |
| GTH-42W |
| HMS3604I12 |
| Hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate (Na+) |
| I06-0478 |
| Indrol |
| J-005667 |
| KS-1028 |
| L-670452 |
| LS-106423 |
| MER-103 |
| MFCD00868112 |
| MFCD01861681 |
| MK 217 |
| MK-0217 |
| MK-217 |
| Monosodium (4-Amino-1-hydroxy-1-phosphonobutyl)phosphonate |
| Monosodium alendronate |
| NeoBon |
| Onclast |
| Osteovan |
| P,P'-(4-Amino-1-hydroxybutylidene)bis-phosphonic acid monosodium salt |
| PHOSPHONATE, (4-AMINO-1-HYDROXY-1-PHOSPHONOBUTYL)-, SODIUM SALT |
| Phosphonic acid, (4-amino-1-hydroxybutylidene)bis-, monosodium salt |
| SC-22170 |
| SCHEMBL328770 |
| sodium (4-amino-1-hydroxy-1-phosphono-butyl)-hydroxy-phosphinate |
| sodium (4-amino-1-hydroxy-1-phosphonobutyl)-hydroxyphosphinate |
| sodium (4-azanyl-1-oxidanyl-1-phosphono-butyl)-oxidanyl-phosphinate |
| SODIUM ALDENDRONATE |
| Sodium alendronate |
| sodium alendronate(1-) |
| sodium hydrogen(4-amino-1-hydroxy-1-phosphonobutyl)phosphonate |
| Steovess |
| Teiroc |
| UNII-4988K7X26P |
| Y-8756 |
US Patents and Regulatory Information for BINOSTO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mission Pharma | BINOSTO | alendronate sodium | TABLET, EFFERVESCENT;ORAL | 202344-001 | Mar 12, 2012 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | Y | ➤ Try a Free Trial | ||
| Mission Pharma | BINOSTO | alendronate sodium | TABLET, EFFERVESCENT;ORAL | 202344-001 | Mar 12, 2012 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | Y | ➤ Try a Free Trial | ||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for BINOSTO
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Austria | 541575 | ➤ Try a Free Trial |
| European Patent Office | 2277503 | ➤ Try a Free Trial |
| Spain | 2448501 | ➤ Try a Free Trial |
| World Intellectual Property Organization (WIPO) | 2004035004 | ➤ Try a Free Trial |
| Denmark | 1490024 | ➤ Try a Free Trial |
| Spain | 2380924 | ➤ Try a Free Trial |
| Canada | 2495886 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
